T-Therapeutics, a biotechnology company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, announced the successful expansion of its Series A financing, raising an additional $32 million.

Unconventional Ventures announced he the first close of Fund II, an €80 million fund dedicated to backing scalable, sustainable companies founded by diverse and underrepresented teams.

Adriana Preda is the First Obama Scholar from Romania, an Executive Board Member at The Social Incubator association, supporting the integration of disadvantaged youths, and the Co-founder of Goodeed USA.

With a volume of over €100 million, Oyster Bay ranks among the largest European venture capital funds exclusively dedicated to the future food market.

Daya Ventures is building the next generation of high-growth FemTech startups to tackle the $1T+ gender health gap.